Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin America
<abstract language="eng">In terms of economics, implementing generic drug policy is nothing other than consolidating (or even, creating) drug markets that set competitive prices, the result of which favors public access to essential drugs. This article approaches the topic of generic...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Pan American Health Organization
2008-01-01
|
Series: | Revista Panamericana de Salud Pública |
Subjects: | |
Online Access: | http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000100008 |
id |
doaj-57104b8d51dc40beb4d465b58a1833fe |
---|---|
record_format |
Article |
spelling |
doaj-57104b8d51dc40beb4d465b58a1833fe2020-11-25T00:54:24ZengPan American Health OrganizationRevista Panamericana de Salud Pública1020-49891680-53482008-01-012315967Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin AmericaFederico Tobar<abstract language="eng">In terms of economics, implementing generic drug policy is nothing other than consolidating (or even, creating) drug markets that set competitive prices, the result of which favors public access to essential drugs. This article approaches the topic of generic drugs from the economic perspective by examining various regulatory models in order to evaluate and leverage generic drug policy implementation options as a mechanism for battling some of the markets’ specific weaknesses. The conclusion is that there is no single unequivocal method for promoting the use of generic drugs, and that the most favorable way to integrate markets may be through a broad combination of alternatives. These alternatives are grouped and analyzed according to the market issues or challenges that must be overcome. Several options are then identified based on the degree of market consolidation to be obtained.http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000100008formulación de políticasmedicamentos genéricossimilarAmérica Latinapolicy makingdrugsgenericLatin America |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Federico Tobar |
spellingShingle |
Federico Tobar Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin America Revista Panamericana de Salud Pública formulación de políticas medicamentos genéricos similar América Latina policy making drugs generic Latin America |
author_facet |
Federico Tobar |
author_sort |
Federico Tobar |
title |
Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin America |
title_short |
Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin America |
title_full |
Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin America |
title_fullStr |
Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin America |
title_full_unstemmed |
Economía de los medicamentos genéricos en América Latina Economy of generic drugs in Latin America |
title_sort |
economía de los medicamentos genéricos en américa latina economy of generic drugs in latin america |
publisher |
Pan American Health Organization |
series |
Revista Panamericana de Salud Pública |
issn |
1020-4989 1680-5348 |
publishDate |
2008-01-01 |
description |
<abstract language="eng">In terms of economics, implementing generic drug policy is nothing other than consolidating (or even, creating) drug markets that set competitive prices, the result of which favors public access to essential drugs. This article approaches the topic of generic drugs from the economic perspective by examining various regulatory models in order to evaluate and leverage generic drug policy implementation options as a mechanism for battling some of the markets’ specific weaknesses. The conclusion is that there is no single unequivocal method for promoting the use of generic drugs, and that the most favorable way to integrate markets may be through a broad combination of alternatives. These alternatives are grouped and analyzed according to the market issues or challenges that must be overcome. Several options are then identified based on the degree of market consolidation to be obtained. |
topic |
formulación de políticas medicamentos genéricos similar América Latina policy making drugs generic Latin America |
url |
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000100008 |
work_keys_str_mv |
AT federicotobar economiadelosmedicamentosgenericosenamericalatinaeconomyofgenericdrugsinlatinamerica |
_version_ |
1725234312097300480 |